Tahoe Therapeutics
Tahoe Therapeutics33About
What does Tahoe Therapeutics do?
Tahoe Therapeutics is a biotechnology company focused on developing innovative treatments for debilitating neurological diseases. Their research aims to address unmet medical needs in conditions such as Alzheimer's disease, Parkinson's disease, and ALS.
What is Tahoe Therapeutics's revenue?
StartupHub estimates Tahoe Therapeutics's annual revenue at $7.4M (range $1.6M to $31.3M, 29% confidence), based on comparable companies in the sector.
What is Tahoe Therapeutics's valuation?
StartupHub estimates Tahoe Therapeutics's effective valuation at $110.7M (range $78.8M to $189.0M, 17% confidence), based on comparable companies in the sector.
How much funding has Tahoe Therapeutics raised?
Tahoe Therapeutics has raised a total of $32M in funding. The most recent round on record is Series A.
Where is Tahoe Therapeutics headquartered?
Tahoe Therapeutics is headquartered in San Mateo, United States.
What industry does Tahoe Therapeutics operate in?
Tahoe Therapeutics operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Neurological Disorders.
No comments yet. Be the first to share your take.